With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1662-01-7,4,7-Diphenyl-1,10-phenanthroline,as a common compound, the synthetic route is as follows.
A solution of (No.5-Ind) Mo (CO) 2 (3-C3H5) (0.20g, 0.65 mmol) in CH2C12 was treated with HBF4. Et2O (1 eq. ). After 10 minutes dme was added in excess and the reaction was left for 15 minutes. 0.27 g (0.8 mmol) of 4, 7-diphenil-1, 10-phenantroline were added and the reaction was left for 2 hours at room temperature. After concentration to about 5 ml and addition of Et20, a ruby complex precipitated. The mixture was filtered and the residue recrystallized from CH2CI2/Et2O (razz 90%). A drawing of the structure and physical data are given in Table 1., 1662-01-7
The synthetic route of 1662-01-7 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; IBET-INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA; WO2005/87783; (2005); A1;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI